Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1998
04/30/1998WO1998017639A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
04/30/1998WO1998017627A1 Substituted gamma aminobutyric acids as pharmaceutical agents
04/30/1998WO1998017624A1 Conformationally restricted polyamines and their use as antineoplastic agents
04/30/1998WO1998017325A2 Covalent polar lipid conjugates for targeting
04/30/1998WO1998017321A1 Gene delivery and expression in areas inaccessible to direct protein delivery
04/30/1998WO1998017320A1 Use of hyaluronan in gene therapy
04/30/1998WO1998017315A2 Permeation enhancers for transdermal drug delivery compositions, devices, and methods
04/30/1998WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
04/30/1998WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998WO1998017306A1 Method for increasing blood insulin levels in mammals
04/30/1998WO1998017300A1 Mucin-mediated immunomodulation
04/30/1998WO1998017297A1 Method for topical treatment of nonviral epithelial disorders
04/30/1998WO1998017295A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
04/30/1998WO1998017294A1 Pharmaceutical and cosmetic formulations with antimicrobial activity
04/30/1998WO1998017293A1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea)
04/30/1998WO1998017292A1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium
04/30/1998WO1998017288A1 Lithium containing medicament for combatting papilloma virus infections
04/30/1998WO1998017287A1 Gas- or gel-filled silicone cushion for treatment of keloid and hypertrophic scars
04/30/1998WO1998017286A1 Therapeutic food composition and method to diminish blood sugar fluctuations
04/30/1998WO1998017285A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
04/30/1998WO1998017284A2 Inhibition of cap-independent protein synthesis and hiv-tar translation by heparin or heparin mimetics, and methods for gene therapy
04/30/1998WO1998017282A1 Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
04/30/1998WO1998017280A1 Method of treatment of heart disease caused by chlamydia pneumoniae
04/30/1998WO1998017279A1 Immune response modifier compounds for treatment of th2 mediated and related diseases
04/30/1998WO1998017278A1 Neurotrophin antagonist compositions
04/30/1998WO1998017277A1 Amidine compounds for use in systemic treating ecto and/or endo parasitic diseases
04/30/1998WO1998017274A1 Thrombin inhibitors
04/30/1998WO1998017273A1 Methods of using butyric acid or butyric acid derivatives to protect against hair loss
04/30/1998WO1998017272A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
04/30/1998WO1998017271A1 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid
04/30/1998WO1998017270A1 Oral compositions containing zinc citrate salts
04/30/1998WO1998017269A1 Use of zinc salts of conjugated linoleic acids to treat skin disorders
04/30/1998WO1998017268A2 Method of alleviating pain by means of combining tramadol with an nmda antagonist
04/30/1998WO1998017267A1 Compositions and methods for treating bone deficit conditions
04/30/1998WO1998017266A2 Pharmaceutical preparation
04/30/1998WO1998017265A1 Pharmaceutical composition containing tromethamine for the topical treatment of acne vulgaris
04/30/1998WO1998017264A1 Composition and method for topical treatment of active herpesviral infections
04/30/1998WO1998017255A1 Preparation for the transport of an active substance across barriers
04/30/1998WO1998017250A1 Pharmaceutical composition for rapid suspension in aqueous media
04/30/1998WO1998017249A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum
04/30/1998WO1998017248A1 Aqueous, antimicrobial liquid cleaning formulation
04/30/1998WO1998017246A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
04/30/1998WO1998017244A1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases
04/30/1998WO1998017231A2 Treatment and delivery of hydroxychloroquine
04/30/1998WO1998017230A2 New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives
04/30/1998WO1998017214A1 Method for treating dementia due to aids
04/30/1998WO1998017195A1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (Eh) LEVELS
04/30/1998WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same
04/30/1998WO1998004249A3 Tramadol multiple unit formulations
04/30/1998WO1997047593A3 Peptides
04/30/1998DE19644422A1 Use of terpene(s) as immunosuppressant, anti-retroviral or anti-leukaemia
04/30/1998DE19644228A1 Thienopyrimidine Thienopyrimidines
04/30/1998CA2751712A1 Immunotherapy and improved vaccines
04/30/1998CA2745736A1 Immunotherapy and improved vaccines
04/30/1998CA2271721A1 Mini-e1a genes and gene products
04/30/1998CA2270154A1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998CA2269825A1 Gene delivery and expression in areas inaccessible to direct protein delivery
04/30/1998CA2269614A1 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998CA2269586A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
04/30/1998CA2269552A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum
04/30/1998CA2269533A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
04/30/1998CA2269506A1 Method for treating dementia due to aids
04/30/1998CA2269349A1 Mucin-mediated immunomodulation
04/30/1998CA2269283A1 Metalloproteinase inhibitors
04/30/1998CA2269127A1 Oral compositions containing zinc citrate salts
04/30/1998CA2269074A1 Immunotherapy and improved vaccines
04/30/1998CA2268930A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
04/30/1998CA2268876A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same
04/30/1998CA2268756A1 Piperidine compounds
04/30/1998CA2268670A1 Preparation for transporting active ingredients through barriers
04/30/1998CA2268476A1 Use of hyaluronan in gene therapy
04/30/1998CA2268418A1 .alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors
04/30/1998CA2268413A1 Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide
04/30/1998CA2268365A1 Il-12 gene expression and delivery systems and uses
04/30/1998CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/30/1998CA2267636A1 Retroviral vectors
04/30/1998CA2267260A1 Thrombin inhibitors
04/30/1998CA2267114A1 1-phenyl-benzimidazole compounds and their use as gaba-a receptor modulators
04/30/1998CA2240997A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
04/30/1998CA2240458A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics
04/30/1998CA2240171A1 Gas- or gel-filled silicone cushion for treatment of keloid and hypertrophic scars
04/30/1998CA2219377A1 Improvements in or relating to the prophylaxis of breast cancer
04/30/1998CA2217785A1 Novel polyhydro derivatives of tylosine and process for their preparation
04/30/1998CA2197008A1 Broncho rub
04/29/1998EP0838470A1 9-N-ethenyl derivatives of 9(S)-erythromycylamine
04/29/1998EP0838469A1 10,13,15-Trioxatricy-clo(9.2.1.1. 9.6)-pentadecanon derivatives, process for their preparation and medicament containing them
04/29/1998EP0838464A1 Substituted benzo(b)thiophene compounds having activity as selective estrogen receptor modulators
04/29/1998EP0838462A1 Benzothiophene compounds, intermediates, compositions, and methods
04/29/1998EP0838461A2 Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
04/29/1998EP0838459A1 Naphthyl compounds, compositions, and methods
04/29/1998EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same
04/29/1998EP0838223A1 Brain edema inhibitor
04/29/1998EP0838220A1 Drug for ameliorating brain diseases
04/29/1998EP0838218A1 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
04/29/1998EP0837952A2 Detection and quantification of human herpesvirus 7 by enzymatic amplification of virus dna
04/29/1998EP0837951A1 Antisense inhibition of hepatitis b virus replication
04/29/1998EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
04/29/1998EP0837934A1 Human vascular endothelial growth factor 2
04/29/1998EP0837933A1 Optimized minizymes and miniribozymes and uses thereof
04/29/1998EP0837932A1 Macrophage activating factors derived from cloned vitamin d binding protein
1 ... 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 6673 6674 6675 6676 6677 6678 6679 6680 6681 ... 7860